ECS Botanics Holdings Ltd (ECS) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of ECS Botanics Holdings Ltd stock A$0.00, price A$0.00, that is 10.0% below the price, quality 30 out of 100. Rating: overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
ECS Botanics Holdings Ltd
ECS · AUExpensive (fair value 10% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range A$0.0030 – A$0.0430 · the A$0.0040 price screens above the A$0.0036 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 5 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 14, 2026.
Every Wednesday you see whether ECS Botanics Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.
Stock analysis
ECS Botanics Holdings Ltd (ECS) currently trades at A$0.0040, while our model-based Fair Value estimate is A$0.0036, 10% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
ECS Botanics Holdings Ltd reported revenue of A$21.0M in FY2026 versus A$5.3M in FY2022, a compound +41.1%/yr. Reported net income was −A$1.9M in FY2026.
Key figures
Market cap A$6.4M (≈ $4.3M) Micro · P/S ratio 0.38 · Net margin −9.1% · Return on equity −8.4% · Return on assets (EBIT) −13.5% (5-year average) · Operating margin −8.6% · Revenue (TTM) A$21.0M · Revenue growth (YoY) +0.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 33% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −10%, ECS screens cheaper than that median.
Fair Value models
All 1 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
ECS screens overvalued: fair value 10% below the price. Compare with Merck KGaA →
Compare ECS Botanics Holdings Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Valuation of the Australia market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs ECS |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs ECS |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs ECS |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs ECS |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs ECS |
| Galderma Group GALD | CHF 191.00 | CHF 112.46 | −41% | vs ECS |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs ECS |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs ECS |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs ECS |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs ECS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is ECS Botanics Holdings Ltd (ECS) overvalued or undervalued?
What is the fair value of ECS?
What is the quality score of ECS?
What is the price target for ECS Botanics Holdings Ltd (ECS)?
What is the ECS Botanics Holdings Ltd stock forecast for 2026?
What is the revenue of ECS Botanics Holdings Ltd (ECS)?
What is the intrinsic value of ECS Botanics Holdings Ltd (ECS)?
Is ECS Botanics Holdings Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of ECS?
How much is ECS Botanics Holdings Ltd worth?
How solid is the balance sheet of ECS Botanics Holdings Ltd (ECS)?
How far is ECS from its 52-week high?
Which stocks are comparable to ECS Botanics Holdings Ltd?
Is ECS Botanics Holdings Ltd stock attractive at the current price?
How is the fair value of ECS calculated?
Is it still worth investing in stocks now?
What is the share price of ECS Botanics Holdings Ltd (ECS)?
What should I pay attention to with ECS Botanics Holdings Ltd right now?
Key figures of ECS Botanics Holdings Ltd
How large is the market capitalisation of ECS Botanics Holdings Ltd (ECS)?
What is the P/S ratio of ECS Botanics Holdings Ltd (ECS)?
What is the net margin of ECS Botanics Holdings Ltd (ECS)?
What is the return on equity of ECS Botanics Holdings Ltd (ECS)?
What is the EBIT return on assets of ECS Botanics Holdings Ltd (ECS)?
What is the operating margin of ECS Botanics Holdings Ltd (ECS)?
How fast is revenue growing at ECS Botanics Holdings Ltd (ECS)?
How fast are earnings growing at ECS Botanics Holdings Ltd (ECS)?
How much free cash flow does ECS Botanics Holdings Ltd (ECS) generate?
How much net debt does ECS Botanics Holdings Ltd (ECS) carry?
Watch ECS Botanics Holdings Ltd in the live analysis
One click puts ECS Botanics Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.